| Title |
A randomized multicenter clinical trial to evaluate the efficacy of melatonin in the prophylaxis of SARS-CoV-2 infection in high-risk contacts (MeCOVID Trial): A structured summary of a study protocol for a randomised controlled trial
|
|---|---|
| Published in |
Trials, June 2020
|
| DOI | 10.1186/s13063-020-04436-6 |
| Pubmed ID | |
| Authors |
Irene García García, Miguel Rodriguez-Rubio, Amelia Rodríguez Mariblanca, Lucía Martínez de Soto, Lucía Díaz García, Jaime Monserrat Villatoro, Javier Queiruga Parada, Enrique Seco Meseguer, María J. Rosales, Juan González, José R. Arribas, Antonio J. Carcas, Pedro de la Oliva, Alberto M. Borobia |
X Demographics
The data shown below were collected from the profiles of 26 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 5 | 19% |
| Spain | 2 | 8% |
| Mexico | 2 | 8% |
| Sao Tome and Principe | 1 | 4% |
| India | 1 | 4% |
| Brazil | 1 | 4% |
| Unknown | 14 | 54% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 16 | 62% |
| Practitioners (doctors, other healthcare professionals) | 5 | 19% |
| Scientists | 4 | 15% |
| Science communicators (journalists, bloggers, editors) | 1 | 4% |
Mendeley readers
The data shown below were compiled from readership statistics for 556 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 556 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 65 | 12% |
| Researcher | 64 | 12% |
| Student > Master | 60 | 11% |
| Student > Ph. D. Student | 27 | 5% |
| Other | 25 | 4% |
| Other | 100 | 18% |
| Unknown | 215 | 39% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 136 | 24% |
| Nursing and Health Professions | 53 | 10% |
| Pharmacology, Toxicology and Pharmaceutical Science | 19 | 3% |
| Biochemistry, Genetics and Molecular Biology | 18 | 3% |
| Psychology | 15 | 3% |
| Other | 76 | 14% |
| Unknown | 239 | 43% |